← Back to Search

Primary Care Program for Breast Cancer Management

N/A
Waitlist Available
Led By Shawna V Hudson, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up repeated measures at baseline, 6 months, 12 months, 18 months and 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether a program to help manage breast cancer symptoms and risks is effective.

Who is the study for?
This trial is for staff members or patients who have had breast cancer and are part of a participating practice. They must be able to speak, understand, and read English as well as provide informed consent.
What is being tested?
The study is testing an organizational intervention aimed at improving the management of symptoms and risks in breast cancer survivors within primary care settings.
What are the potential side effects?
Since this trial focuses on an organizational intervention rather than a medical treatment, it does not involve typical medication side effects. However, there may be indirect effects related to changes in healthcare practices.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand and give consent for treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~repeated measures at baseline, 6 months, 12 months, 18 months and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and repeated measures at baseline, 6 months, 12 months, 18 months and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Comprehensive Breast Cancer Follow-up Care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Practice Led InterventionActive Control1 Intervention
Clinic staff will participate in learning collaborative and practice facilitation as well as receive expert consultation and audit and feedback.
Group II: Standard of CareActive Control1 Intervention
No intervention.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,111,670 Total Patients Enrolled
943 Trials studying Breast Cancer
1,443,132 Patients Enrolled for Breast Cancer
Rutgers, The State University of New JerseyLead Sponsor
455 Previous Clinical Trials
69,041 Total Patients Enrolled
15 Trials studying Breast Cancer
1,000 Patients Enrolled for Breast Cancer
Shawna V Hudson, PhDPrincipal InvestigatorRutgers University

Media Library

Practice Led Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05400941 — N/A
Breast Cancer Research Study Groups: Practice Led Intervention, Standard of Care
Breast Cancer Clinical Trial 2023: Practice Led Intervention Highlights & Side Effects. Trial Name: NCT05400941 — N/A
Practice Led Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05400941 — N/A
~607 spots leftby Jul 2026